Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

Jan 29, 2025 · DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments. Danaher Q4 Earnings Miss Estimates, Life Sciences ...

CouponFollow Extension

1%
OFF

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

2 weeks from now

zacks.com

4%
OFF

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

2 weeks from now

Jan 29, 2025 · Danaher Corporation’s DHR fourth-quarter 2024 adjusted earnings of $2.14 per share missed the Zacks Consensus Estimate of $2.17. The bottom line increased 2.4% year …

yahoo.com

4%
OFF

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

2 weeks from now

Danaher Corporation’s DHR fourth-quarter 2024 adjusted earnings of $2.14 per share missed the Zacks Consensus Estimate of $2.17. The bottom line increased 2.4% year over year.Stay up …

barchart.com

5%
OFF

Danaher Shares Fall As Q4 Earnings Miss Estimates, Revenue Beats

2 weeks from now

Jan 29, 2025 · Investing.com -- Danaher Corporation reported fourth quarter 2024 results that missed earnings estimates but beat on revenue, sending shares down 5% in early trading. The …

investing.com

$2.14
OFF

Danaher (DHR) Lags Q4 Earnings Estimates - Nasdaq

2 weeks from now

Jan 29, 2025 · Danaher (DHR) came out with quarterly earnings of $2.14 per share, missing the Zacks Consensus Estimate of $2.17 per share. This compares to earnings of $2.09 per share …

nasdaq.com

5%
OFF

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

2 weeks from now

Jan 24, 2025 · The Zacks Consensus Estimate for revenues is pegged at $6.44 billion, which indicates an increase of 0.5% from the year-ago quarter’s figure. The consensus mark for …

yahoo.com

3%
OFF

Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag

2 weeks from now

Jan 29, 2025 · Danaher's Q4 adjusted EPS missed estimates, while sales of $6.54B exceeded forecasts, driven by biotech and life sciences growth. The diagnostics segment saw a 3% …

benzinga.com

$43
OFF

Danaher Reports Fourth Quarter And Full Year 2024 Results - PR …

2 weeks from now

Jan 29, 2025 · C. Impairment charges related to a trade name in the Diagnostics segment recorded in the three-month period and year ended December 31, 2024 ($43 million pretax as …

prnewswire.com

$2.03
OFF

Danaher Fourth-Quarter Earnings Miss Estimates; Expects Decline …

2 weeks from now

Sales in the life sciences division inclined to $2.03 billion from $1.93 billion in the prior-year quarter, while biotechnology gained to $1.87 billion from $1.76 billion.

msn.com

1%
OFF

Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates - Yahoo Finance

2 weeks from now

Jan 31, 2025 · Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. …

yahoo.com

4%
OFF

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

2 weeks from now

Jan 29, 2025 · Danaher Corporation’s DHR fourth-quarter 2024 adjusted earnings of $2.14 per share missed the Zacks Consensus Estimate of $2.17. The bottom line increased 2.4% year …

tradingview.com

1%
OFF

Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates

2 weeks from now

Jan 31, 2025 · Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. …

financialcontent.com

1%
OFF

Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates

2 weeks from now

Diversified science and technology company Danaher (NYSE:DHR) in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per share was 1.3% below …

msn.com

FAQs about Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y Coupon?

How much did Danaher sell?

Danaher reported net sales of $6.5 billion, which beat the consensus estimate of $6.4 billion. The metric increased 2.1% year over year, driven by robust sales in the Diagnostics and Life Sciences segments. DHR’s core sales increased 1%. ...

Does Danaher Corporation (DHR) beat the Zacks consensus estimate?

Danaher Corporation ’s DHR fourth-quarter 2024 adjusted earnings of $2.14 per share missed the Zacks Consensus Estimate of $2.17. The bottom line increased 2.4% year over year. Stay up-to-date with all quarterly releases: See ZacksEarnings Calendar. Danaher reported net sales of $6.5 billion, which beat the consensus estimate of $6.4 billion. ...

How did Danaher perform in Q4 cy2024?

Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per share was 1.3% below analysts’ consensus estimates. Is now the time to buy Danaher? Find out in our full research report. ...

When will Danaher Corporation (DHR) release Q4 earnings?

Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock? Danaher Corporation DHR is scheduled to release fourth-quarter 2024 results on Jan. 29, before market open. Stay up-to-date with all quarterly releases: See ZacksEarnings Calendar. ...

How much cash did Danaher generate in 2024?

Danaher generated net cash of $6.68 billion from operating activities in 2024 compared with $6.49 billion in the previous year’s comparable period. Capital expenditures totaled $1.39 billion in the same period, up 0.7% year over year. Adjusted free cash flow increased 3.5% year over year to $5.31 billion in 2024. ...

When will Danaher Corporation (DHR) release fourth-quarter 2024 results?

Danaher Corporation DHR is scheduled to release fourth-quarter 2024 results on Jan. 29, before market open. Stay up-to-date with all quarterly releases: See ZacksEarnings Calendar. The Zacks Consensus Estimate for revenues is pegged at $6.44 billion, which indicates an increase of 0.5% from the year-ago quarter’s figure. ...